Delivery Order SPE2DB24D1205-SPE2DB25FDAEM
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,738.03 on August 29, 2025, for the supply of Jardiance 10 mg tablets in a 90-count quantity. This is a firm fixed-price delivery order with no set-aside designation, completed through competitive procurement. The order is scheduled for delivery to the AmerisourceBergen facility in Conshohocken, Pennsylvania, with an ultimate completion date of September 2, 2025. Jardiance (empagliflozin) is a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Jardiance 10 mg tablets in a 90-count package. This delivery order, valued at $26,553.55, represents a firm fixed-price contract with no set-aside designation, reflecting a competitively awarded procurement. The contract is scheduled for completion by September 4, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Jardiance 10 mg tablets in a quantity of 90 units. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $18,493.98 and is scheduled for completion by August 4, 2025. The contract involves no set-aside designation and identifies AmerisourceBergen's Conshohocken, Pennsylvania facility as the place of performance. Jardiance is a widely-used...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Jardiance 10 mg tablets (90-count) with a ceiling value of $9,728.31. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is due for completion by September 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Jardiance 10 mg tablets (90-count units) with a ceiling value of $8,588.52. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The order is scheduled for ultimate completion by August 19, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Jardiance 10 mg tablets in quantities of 90 units, with a ceiling value of $4,953.99. This is a firm fixed price delivery order with an ultimate completion date of September 5, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the delivery from its corporate office location. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 20, 2025, for the supply of Jardiance 10 mg tablets in a 90-count quantity, with a ceiling value of $7,604.31 and a firm fixed price contract type. This delivery order, which is non-set-aside and competitively awarded, is set to be completed by June 23, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Jardiance 10 mg tablets (90-count) under a firm fixed-price contract valued at $21,295.85. This non-competitive, competitively awarded delivery order is scheduled for completion by August 21, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Jardiance 25 mg tablets (90-count packages) valued at $18,509.94 under a firm fixed-price contract. This is a non-set-aside competitive award executed at the company's Conshohocken, Pennsylvania facility. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Jardiance 10 mg tablets in a quantity of 90 units, with a contract ceiling value of $3,793.64. This is a firm fixed price delivery order with no set-aside designation, utilizing competitive procurement procedures. The order is scheduled for completion by August 7, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken,...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FDAEMDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Jardiance 10 mg tablets (90-count units) with a ceiling value of $11,596.91. This is a firm fixed-price delivery order with no set-aside designation, issued competitively under the company's existing indefinite delivery contract. The order is scheduled for completion by September 8, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Jardiance (empagliflozin) is a widely-used pharmaceutical for managing type 2 diabetes, reflecting the Defense Logistics Agency's ongoing medical supply needs for military and veteran healthcare systems. This delivery order is a child contract executed under AmerisourceBergen's broader Indefinite Delivery Contract (IDC SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor serving federal healthcare programs, AmerisourceBergen maintains a comprehensive portfolio of brand-name and generic medications, vaccines, and medical supplies supporting the Defense Health Agency and other government healthcare systems. The firm fixed-price structure and rapid completion timeline demonstrate the operational efficiency of the company's pharmaceutical supply chain supporting military medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.6k | 9/5/25 |